J&J

J&J Starts Share Exchange Offer For Consumer Health Spin-Off Kenvue

Johnson & Johnson said on Monday that it had launched an exchange offer under which its stockholders can opt for shares of Kenvue, its n...

J&J Spinoff Kenvue Forecasts Upbeat Annual Profit On Self-Care Boost

Kenvue, the former consumer health unit of Johnson & Johnson, forecast full-year profit above Wall Street estimates, betting on resilient demand for it...

J&J Raises Annual Profit Forecast

Johnson & Johnson beat first-quarter profit estimates on Tuesday and raised its 2023 profit forecast.

J&J Forecasts Strong 2023 Profit On Pharma Boost

Johnson & Johnson on Tuesday forecast annual profit above Wall Street estimates.

J&J To End Global Sales Of Talc-Based Baby Powder

Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drugmaker said, more than two years after it ended US sales...

J&J To Stop Selling Personal Care Products In Russia

Johnson & Johnson announced on Tuesday it would halt sale of personal care products in Russia.

Johnson & Johnson Files COVID-19 Vaccine Application With US FDA

Johnson & Johnson has asked U.S. health regulators to authorise its single-dose COVID-19 vaccine for emergency use, and it will apply to European a...

J&J's COVID-19 Vaccine 66% Effective In Large Global Trial

Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple var...

Subscribe Today

Johnson & Johnson Promises Vaccine Data 'Soon'

J&J Says It Could Produce 1bn Doses Of Potential COVID-19 Shot In 2021

J&J Raises Forecast After Quarterly Profit Beats Estimates

Nonprofits Urge Johnson & Johnson To Halt Sales Of Baby Powder Globally

Johnson & Johnson To Stop Selling Talc Baby Powder In U.S. And Canada

J&J Beats Profit Estimates But Cuts Forecast On Coronavirus Uncertainty

J&J To Start Human Testing Of Coronavirus Vaccine By September

ABOUT US

Get the app today!